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Bone formationIn the present study a rat animal model of lathyrism was employed to decipher whether anatomically con-
ﬁned alterations in collagen cross-links are sufﬁcient to inﬂuence the mechanical properties of whole bone.
Animal experiments were performed under an ethics committee approved protocol. Sixty-four female
(47 day old) rats of equivalent weights were divided into four groups (16 per group): Controls were fed a
semi-synthetic diet containing 0.6% calcium and 0.6% phosphorus for 2 or 4 weeks and β-APN treated animals
were fed additionally with β-aminopropionitrile (0.1% dry weight). At the end of this period the rats in the
four groups were sacriﬁced, and L2–L6 vertebra were collected. Collagen cross-links were determined by
both biochemical and spectroscopic (Fourier transform infrared imaging (FTIRI)) analyses. Mineral content
and distribution (BMDD) were determined by quantitative backscattered electron imaging (qBEI), and min-
eral maturity/crystallinity by FTIRI techniques. Micro-CT was used to describe the architectural properties.
Mechanical performance of whole bone as well as of bone matrix material was tested by vertebral compres-
sion tests and by nano-indentation, respectively.
The data of the present study indicate that β-APN treatment changed whole vertebra properties compared to
non-treated rats, including collagen cross-links pattern, trabecular bone volume to tissue ratio and trabecular
thickness, which were all decreased (pb0.05). Further, compression tests revealed a signiﬁcant negative im-
pact of β-APN treatment on maximal force to failure and energy to failure, while stiffness was not inﬂuenced.
Bone mineral density distribution (BMDD) was not altered either. At the material level, β-APN treated rats
exhibited increased Pyd/Divalent cross-link ratios in areas conﬁned to a newly formed bone. Moreover,
nano-indentation experiments showed that the E-modulus and hardness were reduced only in newly formed
bone areas under the inﬂuence of β-APN, despite a similar mineral content.
In conclusion the results emphasize the pivotal role of collagen cross-links in the determination of bone qual-
ity and mechanical integrity. However, in this rat animal model of lathyrism, the coupled alterations of tissue
structural properties make it difﬁcult to weigh the contribution of the anatomically conﬁned material
changes to the overall mechanical performance of whole bone. Interestingly, the collagen cross-link ratio
in bone forming areas had the same proﬁle as seen in actively bone forming trabecular surfaces in human
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Historically osteoporosis has been deﬁned as a disease in which
there is “too little bone, but what there is, is normal” [1]. Although
there is extensive data indicating this deﬁnition has to be modiﬁed
[2], to date, working deﬁnitions of osteoporosis are based predomi-
nantly on bone mass. While evaluations of bone mass are of great
clinical importance, they do not provide any information about the
quality of the remaining bone mineral and matrix (in particular colla-
gen) components [2].
The intermolecular cross-linking of bone collagen is intimately re-
lated to the way collagen molecules are arranged in ﬁbrils. Six major
collagen cross-links have been established as naturally occurring
intermolecular cross-links. They are (i) dehydrodihydroxylysinonor-
leucine (deH-DHLNL) which exists primarily in its ketoamine form,
hydroxylysine-5-keto-norleucine (HLKNL), (ii) dehydrohydroxylysi-
nonorleucine (deH-HLNL) which is also present as the ketoamine,
lysine-5-keto-norleucine (LKNL), (iii) pyridinoline (PYD), (iv) deoxy-
pyridinoline (DPD; lysyl analog of PYD), (v) pyrroles (PYL and DPL),
and (vi) histidinohydroxylysinonorleucine (HHL). The ﬁrst two are
reducible with borohydride (their reduced forms are referred to as
DHLNL, and HLNL, respectively) and the rest are non-reducible com-
pounds [3–6]. In mineralized tissue collagen the predominant cross-
links are: HLKNL, LKNL, PYD, DPD, and pyrroles [7,8].
Data exist showing that the properties of collagen affect the me-
chanical strength of bone [9–11]. Recent clinical reports have corre-
lated plasma homocysteine levels and bone fragility [12–15].
Homocysteine affects bone formation areas and in particular collagen
cross-links [16]. The homocysteine-induced changes in collagen
cross-links at trabecular bone forming and resorbing surfaces are sim-
ilar to those seen in osteoporotic and fragility fracture patients
[17,18]. Moreover, in a recent report employing spectroscopic analy-
sis of iliac crest biopsies from 54 women (aged 30–83 yr; 32 with
fractures, 22 without) who had signiﬁcantly different spine but not
hip Bone Mineral Density (BMD), it was found that cortical and can-
cellous bone collagen cross-link ratio strongly correlated positively
with fracture incidence [19], further emphasizing the contribution
of collagen cross-links in determining bone strength. In addition, in
studies where there was a deviation between BMD values and
bone strength, the spectroscopically determined pyridinoline (PYD)/
divalent collagen cross-link ratio always correlated with bone strength
[18–21]. One puzzling fact with these studies was the observation that
the alterations in collagen cross-link ratio (PYD/divalent) were anatom-
ically restricted to actively forming trabecular surfaces (based on either
histologic stains or the presence of primary mineralized packets), while
the rest of the bone seemed unaffected.
The purpose of the present study was to investigate whether ana-
tomically conﬁned alterations in collagen cross-links are sufﬁcient to
inﬂuence the mechanical performance of whole bone, employing the
well-established β-aminopropionitrile (β-APN) treated rat model
[22,23]. β-aminopropionitrile inhibits the lysyl oxidase-mediated for-
mation of lysine aldehydes which are precursors of the major divalent
and trivalent bone collagen cross-link moieties (HLKNL, LKNL, PYD,
DPD). Vertebral bone was analyzed by μCT, micro ﬁnite element anal-
ysis (μFE), quantitative backscatter electron imaging (qBEI), compres-
sion mechanical testing, nanoindentation, and FTIRI analysis. Collagen
cross-links were determined both chemically and spectroscopically.
Materials and methods
Animals
Under an Ohio State University IACUC-approved protocol, sixty-
four female (47 day old) rats of equivalent weights were divided
into four groups (16 per group): 2 control and 2 treatment groups.
Controls were fed a semi-synthetic diet containing 0.6% calcium and0.6% phosphorus as published elsewhere [24] for 2 or 4 weeks and
β-APN treated animals were fed a diet inclusive of β-aminopropioni-
trile (0.1% dry weight) for 2 or 4 weeks . The 2 and 4 week-time
points were used to allow formation of new bone with varying de-
grees of cross-linking in limited anatomical areas, without affecting
the whole bone. Rats were sacriﬁced at the assigned time points
and intact spines were harvested, dissected free from soft tissue and
stored in 70% ethanol.
Chemical analysis of collagen cross-links
L3 vertebra from each animal were equilibrated with phosphate
buffered saline, pH 7.8, pulverized and reduced with KBH4 for 1 h.
After this time, the pH was adjusted to 4 with acetic acid to destroy
excess reagent, the tissue washed extensively with water and freeze
dried. The reduced bone was hydrolyzed in 6 M HCl at 107 °C for
22 h and the acid was removed by evaporation. Following prelimi-
nary fractionation of cross-linked amino acids by partition chroma-
tography, the intermediate compounds (DHLNL and HLNL) were
assayed by ion-exchange chromatography with post-column deriva-
tization and the mature bonds (PYD and DPD) were quantiﬁed
using RP-HPLC using their natural ﬂuorescence, as described previ-
ously [25]. Cross-link concentrations were expressed relative to colla-
gen content determined by colorimetric measurement of
hydroxyproline in the original hydrolysate. It should be noted here
that both cortical and trabecular bone were included in the analysis.
μCT
The endplates of each L2 vertebra were carefully removed with a
low speed diamond-coated saw (Isomet, Buehler, Germany) to pro-
vide samples with a height of approximately 3 mm. The vertebral
body was then isolated from the posterior elements and one of the
plane surfaces was glued on a carbon rod with a thin layer of cyano-
acrylate glue. The other surface was polished to achieve parallel
faces. The average ﬁnal height was 2.5 mm. The vertebral body was
scanned in 70% ethanol by μCT with a 12 μm voxel size (μCT40,
Scanco, Switzerland). The reconstructions were segmented with an
optimal threshold, separated into trabecular and cortical compart-
ments and standard histomorphometric parameters were computed
with the manufacturer's software (IPL, Scanco, Switzerland).
qBEI
Vertebrae (L5) were ﬁxed in 70% ethanol, dehydrated through a
graded series of ethanol and embedded undecalciﬁed in polymethyl-
methacrylate (PMMA). About 5 millimeter thick blocks containing a
sagittal vertebral bone section were cut using a low speed diamond
saw (Buehler Isomed, Lake Pluff, USA). The section surface was
ground with sand paper and subsequently polished by a diamond
suspension (3 and 1 μm grain size, respectively) using a precision pol-
ishing device (MP5 Logitech, Ltd, Glasgow, Scotland). The sample sur-
face was carbon coated prior to qBEI. A digital electron microscope
(DSM 962, Zeiss, Oberkochen, Germany) equipped with a four quad-
rant semiconductor BE detector was used for backscattered electron
imaging. The accelerating voltage of the electron beam was adjusted
to 20 kV, the probe current to 110 pA, and the working distance to
15 mm. The digital backscattered (BE) images of trabecular bone
areas were acquired by a single frame with a scan speed of 100 s/
frame and a pixel resolution of 1 μm. Areas with high backscattered
electron intensities – light gray levels – represent mineralized matrix
with high Ca contents, whereas areas with low intensities – dark gray
levels – indicate low mineral density. For the characterization and
quantiﬁcation of changes in the bone mineralization density distribu-
tion (BMDD) curve, four outcomes were used: CaMean (the weight
mean calcium content of the bone area obtained from the integrated
Table 1
BMDD parameters of cancellous bone in untreated rats (control) compared with β-APN
treated rats after 2 and 4 weeks of treatment.
2 weeks 4 weeks Two way ANOVA
(p values)
BMDD
parameters
Control β-APN Control β-APN Inter-action Treatment Age
CaMean 22.62 23.00 23.07 23.66 ns ns ns
(wt.% Ca) (0.78) (0.65) (0.57) (0.75)
CaPeak 22.88 23.01 23.26 24.00 ns ns ⁎
(wt.% Ca) (0.68) (0.64) (0.65) (0.60)
CaWidth 3.88 3.71 3.54 3.87 ns ns ns
(Δwt.% Ca) (0.40) (0.31) (0.09) (0.24)
CaLow 4.76 4.10 3.68 4.05 ns ns ns
(% B.Ar) (1.08) (0.71) (0.70) (0.96)
BMDD parameter values are mean and (SD).
⁎ pb0.05.
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indicated by the peak position in the BMDD diagram), CaWidth (the
heterogeneity of mineralization caused by the coexistence of BSU of
different ages measured at the full width at one-half maximum of
the BMDD-peak), CaLow (reﬂects the fraction low mineralized bone
areas (b17.68 wt Ca)). Details of the analysis method have been pub-
lished previously [26].
Additionally, these qBEI images were also used later, to evaluate
the mean gray level/mineral content (CaInd) at the nanoindentation
sites similar as described in Ref. [27].
Mechanical testing
After μCT scanning, the L2 vertebral bodies were rehydrated,
mounted in a servo-hydraulic testing system (858 Mini Bionix II,
MTS, USA), preconditioned with 10 cycles in the elastic range and
tested to failure in axial compression with a rate of 0.033 mm/s. Stiff-
ness, maximal load to failure, and energy to failure were computed
from the resulting force–displacement curves. A mean tissue modulus
for each vertebral body was then back-calculated from the experi-
mental stiffness using a 12 μm resolution, homogeneous, linear elastic
(v=0.3) ﬁnite element model of the same loading scenario.
Nanoindentation was performed using a Scanning Nanoindenter
(Hysitron Inc., Minneapolis, USA) with a Berkovich diamond indenter
tip as described elsewhere [28]. The calibration of the instrument was
performed by doing indents of increasing depth in fused quartz with a
known reduced modulus of 72 GPa. The material properties of the di-
amond tip are known such as the Poisson's ratio is 0.07 and elastic
modulus of the tip is 1140 GPa. Automated area scans of indents
were performed using moving sample stage, which has a positional
resolution of 1 μm. There was a distance of 10 to 11 μm between in-
dents. A thermal drift correction factor was introduced automatically
before each indent, by measuring the drift for 20 s. Before every in-
dent, there was a relaxation time of 60 s and 45 s for stabilizing digital
feedback loop. More than 100 indents were made in the selected re-
gion of size varying from 300 to 500 μm. A maximum load of
5000 μN was used. Anatomical areas were selected based on qBEI im-
ages, and results were normalized for calcium content. The elastic
modulus was calculated using the method of Oliver and Pharr [29],
by ﬁtting the unloading curve with a second order polynomial, differ-
entiating and therefore evaluating the elastic recovery at maximum
load to determine the contact depth. The parameters measured dur-
ing the experiment were peak load (Pmax), peak displacement
hmax, contact area Ac, and stiffness S. The stiffness was calculated
from the slope of the initial unloading curve; the region between 20
and 95% of the maximum load was used to determine the slope of
the unloading curve. The hardness H and reduced modulus Er are cal-
culated from unloading contact stiffness, S, and the indenter contact
area Ac:
H ¼ Pmax=Ac
Er ¼ π1=2S=2Ac1=2
FTIRI analyses
Thin sections (~4 μm) were cut from the L5 vertebrae, and spec-
tral images acquired in the area of trabecular bone using a Bruker
Equinox 55 (Bruker Optics) spectrometer interfaced to a Mercury
Cadmium Telluride (MCT) focal plane array detector (64×64 array)
imaged onto the focal plane of an IR microscope (Bruker Hyperion
3000; Bruker Optics). Each area imaged was 400×400 μm, corre-
sponding to an optimal spatial resolution of ~6.3×6.3 μm. Spectral
resolution was 4 cm−1. Background spectral images were collected
under identical conditions from the same BaF2 windows at thebeginning and end of each experiment to ensure instrument stability.
Both instruments were continuously powered to minimize warm-up
instabilities and purged with dry-air (Bruker Optics) to minimize
the water vapor and CO2 interference. Following this, individual spec-
tra were extracted from trabecular surfaces that were exhibiting ei-
ther primary mineralization packets, or resorption pits, based on the
previously acquired qBEI images (six different trabecular surfaces
per animal were analyzed).
The individual spectra were processed as published elsewhere to
derive the following spectroscopic parameters: (i) Mineral/matrix
ratio (integrated areas under the phosphate (mineral) 900–
1200 cm−1 and amide I 1592–1728 cm−1 (matrix; mainly collagen)
absorbance peaks, respectively; corresponds to ash weight measure-
ments) [30], (ii) mineral maturity/crystallinity (through curve-ﬁtting
of the phosphate (mineral) 900–1200 cm−1 peak and the calculation
of the 1030 to 1020 cm−1 sub-band peak area) [31,32], and (iii) the
ratio of PYD/divalent collagen cross-links (through curve-ﬁtting of
the Amide I and II peaks and the calculation of the 1660 to
1690 cm−1 sub-band peak area) [33]. For each animal, the values of
each parameter at a particular anatomical site (forming or resorbing)
were averaged and the resultant value was treated as a single statis-
tical unit.
Statistical analyses
For each parameter, mean and standard deviation for the two
groups at the two time points were reported. Two-way ANOVA with
Bonferroni post-test analysis was applied to address the following
three questions: i) does age have the same effect at all values of treat-
ment (interaction), ii) does age affect the result, and iii) does treat-
ment affect the result. Where this type of analysis indicated
signiﬁcant differences, additional comparisons were made employing
unpaired t-test. Additionally, 2-way correlations between spectro-
scopically determined pyd/divalent collagen cross-link ratio, structur-
al and mechanical properties were explored using Spearman's test.
Signiﬁcance was assigned to pb0.05.
Results
The animals did not show any effect of the diet during the treatment
period. There was no statistical difference in weight between the con-
trol and β-APN-treated animal groups at either time point although
both groups gainedweight over the twoweek period (data not shown).
Two-way ANOVA of qBEI measurements also showed no statisti-
cally signiﬁcant differences between the animal groups at either
time point in any of the four outcomes monitored (Table 1), with
the exception of CaPeak which was dependent on animal age but
not treatment.
Table 2
Summary of 2-way ANOVA analysis of the biochemically determined collagen cross-links
as well as the spectroscopically determined collagen cross-link ratio (pyd/deH-DHLNL),
along with the appropriate p-values. Statistical signiﬁcance is noted by bold text.
Interaction Age Treatment
DHLNL (biochemical) 0.324 0.014 0.002
HLNL 0.373 0.616 0.104
PYD 0.093 0.755 0.026
DPD 0.759 0.232 b0.0001
PYD/DPD 0.250 0.433 0.080
Biochemically determined 0.028 0.005 0.010
PYD/divalent
Spectroscopically determined 0.514 0.616 0.001
PYD/divalent at forming trabeculae
Spectroscopically determined 0.609 0.790 0.0001
PYD/divalent at periosteal surfaces
Table 3
Summary of 2-way ANOVA analysis of the vertebral bone structural properties as de-
termined by μCT, along with the appropriate p-values. Statistical signiﬁcance is noted
by bold text.
Interaction Age Treatment
Trab_BV/TV 0.443 0.454 0.0005
Trab_TRI-SMI 0.573 0.154 0.0002
Trab_DT-Tb.Th 0.482 0.012 b0.0001
Trab_DIM-Z 0.466 0.003 0.234
Cort_DT-Ct.Th 0.472 b0.0001 b0.0001
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pendent on both animal age and treatment, while PYD and DPD
were dependent only on treatment. The calculated PYD/divalent
cross-link ratio was dependent on both animal age and treatment
(Table 2). Further comparisons using unpaired t-tests showed signif-
icant differences in DHLNL, between control and β-APN-treated ani-
mals at the 4 week time point, and a time-dependent difference in
the β-APN treated animals at 2 and 4 weeks (Fig. 1a). The concentra-
tion of the trivalent cross-link PYD was signiﬁcantly different be-
tween the control and β-APN treated animals at the 4-week time
point (Fig. 1b). The other trivalent collagen cross-link, DPD, was sig-
niﬁcantly different between control and treated animals at both
time points (Fig. 1c). The calculated ratio between PYD/DHLNL was
increased in both groups as a function of time, and was elevated in
the 4 week treated animal group compared to the 2 week treated
and the 4 week control groups (Fig. 1d).Fig. 1. Biochemical analysis of vertebrae revealed signiﬁcant differences in DHLNL (a), PYD (
The ratio of PYD/DHLNL collagen cross-links exhibited the most dramatic differences (d). S
listed.Two-way ANOVA analysis (Table 3) of structural parameters de-
termined by μ-CT analysis of vertebral bone revealed no interaction
between factor age and treatment. Trabecular BV/TV and TRI-SMI
were inﬂuenced only by treatment, trabecular thickness by age and
treatment, and trabecular DIM-Z by age only. Additionally, cortical
thickness was inﬂuenced by both age and treatment. Further statisti-
cal analysis employing unpaired t-tests a signiﬁcantly lower BV/TV in
the treated animals at 4 weeks compared to the corresponding con-
trols (Fig. 2a). Differences in Structural Model Index (TRI-SMI) were
also observed with age and in treated animals for 4 weeks compared
to corresponding controls (Fig. 2b). Trabecular thickness was lower in
the treated animals compared to their respective controls at both
time points (Fig. 2c).
Analysis of the compression testing of vertebrae based on two-
way ANOVA (Table 4) showed no signiﬁcant interaction between fac-
tor age and treatment. Stiffness and maximum force to failure were
affected by both age and treatment, energy to failure was affected
only by treatment. The predicted tissue modulus (based on ﬁnite ele-
ment analysis) was dependent on age but not treatment. Unpaired
t-test comparisons showed signiﬁcant increases in stiffness within
each group as a function of time (age) (Fig. 3a). Signiﬁcant increasesb), and DPD (c) collagen cross-links between normal (CO) and treated (bAPN) animals.
igniﬁcant differences among groups are shown by solid lines, and appropriate p values
Fig. 2. μ-CT analysis of vertebral trabecular bone revealed a signiﬁcantly lower BV/TV in
the treated (bAPN) animals at 4 weeks compared to controls (CO) (a). Signiﬁcant differ-
ences in structural model index (TRI-SMI) were also observed with age and in treated an-
imals for 4 weeks compared to controls (b). Trabecular thickness was lower in the treated
animals compared to their respective controls at both time points (c). Signiﬁcant differ-
ences among groups are shown by solid lines, and appropriate p values listed.
1236 E.P. Paschalis et al. / Bone 49 (2011) 1232–1241in maximum force to failure were observed both as a function of age
within each group, as well as in treated groups at both time points
(Fig. 3b). Energy to failure was signiﬁcantly lower in the treated forTable 4
Summary of 2-way ANOVA analysis of the vertebral bone actual mechanical properties
(compression), as well as the predicted ones (through ﬁnite element analysis), along
with appropriate p-values. Statistical signiﬁcance is noted by bold text.
Interaction Age Treatment
Stiffness 0.709 b0.0001 0.022
Maximum force to failure 0.123 b0.0001 b0.0001
Energy to failure 0.389 0.097 0.014
FE_stiffness 0.402 0.268 0.201
FE_tissue modulus 0.537 b0.0001 0.4734 weeks animals compared to respective controls (Fig. 3c). Interest-
ingly, FE analysis based on the μ-CT data predicted signiﬁcant differ-
ences only for the tissue modulus in the treated animal groups as a
function of age (Fig. 3d).
The qBEI image taken before the nanoindentation experiment
showed the typical region selected for testing in one β-APN treated rat
(Fig. 4a) and the image observed by environmental scanning electron
microscopy (ESEM) after indentation shows the line of indents marked
by red circles (Fig. 4b). The ESEM image was overlaid on to the qBEI
image and small square grids were placed over the indents and the
quantitative mineral content at these points was extracted from the rel-
evant pixels on the qBEI image taken before indentation (Fig. 4c). The
mapping of calcium content from the qBEI measurements and themap-
ping of mechanical properties such as the indentation modulus, Er, and
the hardness are shown in Figs. 4 (d–f). The calcium content was found
to be lower in newly formed regionnear theouter sides of the trabeculae
and, accordingly, lower stiffness and hardness values were observed in
these newly formed bone regions. The relation between the indentation
moduli and the local calciumcontent is represented in Fig. 4g. The values
of the indentation modulus and of the hardness in the newly formed
bone of the β-APN treated tissues are decreased by 35% (pb0.001) and
40% (pb0.003), respectively, compared to control samples in areas
with 19 wt.% calcium or less, which typically correspond to newly
formed bone. For older mature bone, with calcium content typically
higher than 19 wt.%, there were no signiﬁcant changes in the indenta-
tion modulus or in the hardness (Figs. 4h and i).
Spectroscopic analysis of L5 vertebrae revealed no signiﬁcant dif-
ferences between control and treated animals in mineral to matrix
ratio as a function of either animal age or treatment (based on two-
way ANOVA analysis; data not shown) in any of the surfaces ana-
lyzed. Additionally, there were no signiﬁcant differences in mineral
maturity/crystallinity at any of the examined surfaces between nor-
mal and treated groups at either time point (data not shown). On
the other hand, two-way ANOVA analysis indicated that changes in
the spectroscopically determined PYD/divalent collagen cross-link
ratio were dependent on treatment but not age (Table 2), in the
areas of periosteal (cortical) and primary mineralized trabecular sur-
faces. No differences were discernible in secondary mineralized tra-
becular surfaces (Fig. 5). Statistical comparisons based on unpaired
t-tests indicated that there were signiﬁcant differences in this ratio
in primary mineralized trabecular areas (Fig. 6a), with treated ani-
mals exhibiting a signiﬁcantly higher PYD/divalent collagen cross-
link ratio compared to the corresponding controls, regardless of treat-
ment duration. Since this is a ratio, the observed increase could be
due to several possibilities regarding the change in the individual fac-
tors. To further discern the reason for the observed increase in the
treated animals, the relative % area of the individual underlying
bands (1660 and 1690 cm−1, representative of Pyd and divalent col-
lagen cross-links, respectively) were plotted (Fig. 6b), revealing a dis-
proportionate decrease in Pyd and divalent collagen cross-links, in
agreement with the biochemical analysis data. Similar ﬁndings were
observed when the cortical periosteal surfaces were compared
(Figs. 6c and d, respectively).
The results thus far indicated that β-APN treatment affected bone
structural properties, collagen cross-links in anatomically conﬁned
areas (primarymineralized packets in trabecular, and periosteal cortical
surfaces), and mechanical properties. The statistically signiﬁcant corre-
lations between these outcomes along with the Spearman's rho value
are listed in Table 5. Stiffness correlates well with biochemically, and
spectroscopically determined trabecular Pyd/divalent collagen cross-
links, and cortical thickness (Ct.Th).Maximum force to failure correlates
well with biochemically, and spectroscopically determined trabecular
pyd/divalent collagen cross-links, TriSmi, Tb.Th, and Ct.Th. Finally, max-
imum energy to failure correlates well with biochemically determined
Pyd/divalent collagen cross-link ratio, Ct.Th, and periosteal Pyd/divalent
collagen cross-link ratio.
Fig. 3. Compression mechanical testing of vertebrae revealed signiﬁcant increases in stiffness within each group as a function of time (a), signiﬁcant increases in maximum force to
failure both as a function of age within each group, as well as in treated groups at both time points (b), signiﬁcantly lower energy to failure in the treated for 4 weeks animals com-
pared to respective controls (c). Finite Element analysis based on the μ-CT data predicted signiﬁcant differences only for the tissue modulus in the treated (bAPN) animal groups as a
function of age (d). Signiﬁcant differences among groups are shown by solid lines, and appropriate p values listed.
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The results of the present study employing a lathyritic rat animal
model indicate that collagen cross-links coupled with structural
changes are a major contributor to bone strength, in line with previ-
ously published reports in animal models and human tissue
[22,23,34–39]. They also indicate a correlation with bone structural
properties, in agreement with previously published results [40].
They additionally indicate that even when these changes are anatom-
ically restricted (in the present case only in primary mineralized
bone), coupled with changes in bone structural properties, they are
sufﬁcient to inﬂuence the mechanical performance of whole bone,
even in the absence of concomitant mineral quantitative and/or qual-
itative properties alterations. Moreover, ﬁnite element analysis is not
capable of predicting the full breadth of such an effect on bone
strength.
Recent publications have reported that bone plastic deformation
properties are determined not only by mineral content, but also by
the organic matrix and interactions between these two components
[41], and that tissue mineral density is an incomplete surrogate for
tissue elastic modulus [42]. Bone structural and material properties
(including mineral density expressed as mineral/matrix, mineral ma-
turity/crystallinity and collagen cross-links) are important contribu-
tors to bone strength [2]. Moreover, the organic matrix is proposed
to play an important role in alleviating damage to mineral crystallites,
and to matrix/mineral interfaces, behaving like a soft wrap around
mineral crystallites thus protecting them from the peak stresses,
and homogenizing stresses within the bone composite [2,43,44].
The importance of collagen properties in determining bone strength
is emphasized by several publications in the literature reportingaltered collagen properties associated with fragile bone, in both ani-
mals and humans [6,17,18,22,34,37–39,45–51].
Employing FTIRI analyses, we have previously reported altered
collagen cross-link ratio (PYD/divalent) in forming trabecular sur-
faces in osteoporotic patients and patients with fragility fractures
[17,18]. The surprising ﬁnding was that these alterations compared
to normal bone were restricted in forming surfaces only, thus wheth-
er these alterations were important contributors to bone fragility
remained in question. To address this, an animal model was utilized
in the present study to test the hypothesis that even anatomically
conﬁned alterations in collagen cross-links can affect whole bone me-
chanical performance independent of mineral. It has been previously
shown that in vivo β-APN treatment causes signiﬁcant changes in the
mechanical properties of rat femora (26% decrease in failure stress
and a 30% decrease in elastic modulus as determined in a bending
test after 30 days of treatment) [22], and that it affects the cross-linking
of collagen in the dosage used in the present study [52–56].
β-APN treatment, as expected, caused signiﬁcant reductions in
vertebral DHLNL, PYD, and DPD cross-links, as well as the calculated
Pyd/divalent collagen cross-link ratio, as determined through bio-
chemical analysis of whole bone homogenate. Interestingly, the alter-
ations in divalent and trivalent cross-link concentrations were
disproportionate; thus there were signiﬁcant increases in the PYD/
DHLNL ratio in the treated animals compared to corresponding con-
trols whereas the treatment effects on HLNL were much less marked
than for DHLNL. Although a relative decrease in the proportion of
DHLNL with animal age may have contributed to the results, the ob-
served changes were primarily due to the administration of β-APN.
This inhibitor of lysyl oxidase might be expected to act equally on
the divalent precursors of the non-reducible cross-links but their
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Fig. 4. The qBEI image taken before the nanoindentation experiment shows the typical region selected for testing in one β-APN treated rat (a) and the image observed by environ-
mental scanning electron microscopy (ESEM) after indentation shows the line of indents marked by red circles (b). The ESEM image was overlaid on to the qBEI one, small square
grids were placed over the indents and the quantitative mineral content at these points was extracted from the relevant pixels on the qBEI image taken before indentation (c). The
mapping of calcium content from the qBEI measurements and the mapping of mechanical properties such as the indentation modulus, Er, and the hardness are shown in panels d–g.
The elastic modulus and hardness are reduced in the treated samples (h and i), in the low calcium range (18–24wt.%) of new bone, compared to untreated control samples.
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LH1 and LH2b, which control hydroxylation of lysine in the helix and
telopeptides, respectively. It is tempting to speculate that β-APNCO
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Fig. 5. No signiﬁcant differences were observed among the 4 animal groups in the spec-
troscopically derived Pyd/divalent collagen cross-link ratio, when trabecular surfaces
with evident resorption pits were considered.treatment may also affect other enzyme activities leading to dispro-
portionate changes in amounts of cross-links.
FTIRI spectroscopic analysis of L5 vertebrae indicated that the alter-
ations in the PYD/divalent ratio were conﬁned in areas of trabecular sur-
faces with primary mineralization evident (i.e. forming), and periosteal
surfaces of cortical bone, with β-APN-treated animals exhibiting a higher
ratio compared to the corresponding controls. This increase was due to a
disproportionate decrease of individual components, in excellent agree-
ment with the results of the biochemical analysis. It should be empha-
sized that this increase does not imply that it is solely responsible for
the observed differences in mechanical performance (decreases in all of
collagen cross-links contribute to the inferior mechanical behavior of
the treated animals), but Pyd, divalent, and the corresponding ratio are
the only cross-links that can be spectroscopically monitored, to date.
The discrepancy in the magnitude of change between the
biochemically- and spectroscopically-determined ratio is most likely
due to the fact that as we have previously reported the relationship be-
tween biologically- and spectroscopically-determined cross-link concen-
trations of Pyd is not a linear one [33]. Interestingly, while the
biochemically determined PYD/divalent ratio alterationswere dependent
Fig. 6. Spectroscopic analysis of L5 vertebrae revealed signiﬁcant differences in Pyd/divalent collagen cross-link ratio between normal (CO) and treated (bAPN) animals in primary
mineralized areas of trabecular bone at both time points (a). When the individual components of this ratio are considered individually it becomes apparent that the source of the
observed increase of the ratio is due to a disproportionate decrease of its individual components (b). Similar results were observed when cortical periosteal surfaces were consid-
ered (c and d). Signiﬁcant differences among groups are shown by solid lines, and appropriate p values listed.
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were affected only by treatment (Table 2). This is most likely due to the
fact that while the former is determined in bone of all tissue ages, the lat-
ter normalizes for tissue age through selection of anatomical areas of sim-
ilar tissue age, and accentuates the importance of doing so when
employing microscopic techniques for the determination of bone quality
and in particular collagen properties, as differing tissue age is a confound-
ing factor. When trabecular surfaces with evident resorption pits were
considered, no signiﬁcant differences were observed among the 4 animal
groups. This ismost likely attributable to the fact that this bone tissue is of
older age, formed prior to β-APN administration, and thuswas not affect-
ed by the lathyrogen administration.
Mineral content is a major contributor to bone stiffness. In the
present study, mineral content was determined by two differentTable 5
Correlation coefﬁcient (r) between bone mechanical and structural properties and spectros
indicated by text in bold.
Biochemically determined
pyd/divalent collagen
cross-link ratio (whole bone)
Spectroscopically determi
pyd/divalent collagen cros
ratio at primary mineraliz
trabecular surfaces
Stiffness −0.564⁎ −.856⁎⁎
Maximum force to failure 0.540⁎ .700⁎⁎
Maximum energy to failure −0.487⁎⁎ ns
⁎ Correlation is signiﬁcant at the 0.05 level (2-tailed).
⁎⁎ Correlation is signiﬁcant at the 0.01 level (2-tailed).methods: qBEI and FTIRI. The ﬁrst technique provides the weight frac-
tion mineral in each pixel/voxel of a scanned bone area by means of
backscattered electron intensities (mirroring average atomic num-
bers) [26], while FTIRI provides information in a voxel of a thin
bone section on amount of mineral normalized to the amount of or-
ganic matrix present by means of the ratio between the integrated
areas of PO4 (mineral) and amide I (mainly collagen) bands [57].
Both techniques have been shown to correspond to ash weight mea-
surements [30,57,58], and be a good predictor of bone bending stiff-
ness, correlating well with tissue stiffness and hardness [19,59–61].
In the present work, neither technique indicated any signiﬁcant
changes as a function of treatment.
Mineral maturity/crystallinity also contributes to bone strength
[2,57]. In the present work, there were no differences between anycopically determined pyd/divalent collagen cross-link ratio. Signiﬁcant correlations are
ned
s-link
ed
Spectroscopically determined
pyd/divalent collagen cross-link
ratio at periosteal cortical surfaces
BV/TV TriSmi Tb.Th Ct.Th
ns ns ns ns .466⁎⁎
ns ns .313⁎ −.316⁎ −.658⁎⁎
−0.279⁎ ns ns ns .374⁎⁎
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tions were compared by FTIRI. This may be due to the fact that β-
APN interferes with collagen post-translational modiﬁcations only,
and the time of treatment (up to 4 weeks) was not sufﬁcient for the
changes in collagen post-translational modiﬁcations to induce signif-
icant changes in either mineral amount and/or quality.
Bone structural properties were also affected by β-APN treatment.
While changes in trabecular BV/TV and TRI-SMI were affected by
treatment only, changes in trabecular thickness and DIM-Z as well
as cortical thickness were dependent on both animal age and treat-
ment received, thus making it harder to interpret the latter in the
context of altered collagen cross-links only (Table 3). These chemical
and structural changes most likely contributed to the compromised
mechanical properties in the treated animals. One potential reason
for these observed changes in structural properties could be the fact
that β-APN treatment affects osteoblasts both directly and indirectly
[62,63], in addition to its well-established effect on collagen post-
translational modiﬁcations. Unfortunately, the analyses reported in
this manuscript cannot discern between the two effects.
Compression mechanical tests indicated differences among the
various animal groups in bone stiffness, maximum force to failure,
and energy to failure, the ﬁrst two being affected by both animal
age and treatment, while the third only by treatment. Cortical thick-
ness correlated well with stiffness, maximum force to failure and
maximum energy to failure. These data suggest a major role of corti-
cal thickness in determining vertebral bone strength and in particular
stiffness, a ﬁnding that is in agreement with previously published re-
ports [64–69]. The biochemically determined Pyd/divalent collagen
cross-links ratio correlated with stiffness (inversely), maximum
force to failure, and maximum energy to failure (inversely). The fact
that collagen cross-links correlate well with vertebral biomechanical
properties is in agreement with previously published reports [36].
The spectroscopically determined PYD/divalent collagen cross-link
ratio of primary mineralized trabecular bone correlated well with
maximum force to failure and stiffness. Stiffness correlated negatively
with the Pyd/divalent ratio (due to a disproportionate decrease in the
individual components of the ratio). Additionally, this ratio at perios-
teal cortical surfaces correlated with maximum energy to failure
(inversely).
Structural properties TriSmi and Tb.Th correlated only with maxi-
mum force to failure. In contrast, μFE analysis did not show any effect
of treatment on stiffness, potentially due to the fact that the alteration
of collagen cross-links was combined with preservation of the miner-
alization parameters as described by qBEI analysis. To determine the
anatomical locations of compromised mechanical performance
bone, nanoindentation tests (corrected for amount of mineral present
based on qBEI analysis) were performed. The results indicated that
the mechanical performance differences between control and β-APN
treated animals are limited to areas of lower mineralization, a logical
outcome given the fact that the β-APN effect on bone was necessarily
restricted to bone that was formed during the period of treatment. It
is also in the same anatomical areas that the spectroscopically deter-
mined collagen cross-link ratio (Pyd/divalent) was altered. The fact
that there were no differences in these bone areas between the ani-
mals either in mineral content or in maturity/crystallinity suggests
that the observed differences in mechanical properties were due to
alterations of collagen. In this context it may be worth remarking
that small local conﬁned changes in mechanical properties of a com-
posite material are not likely to affect the overall modulus of the bone
material, which is always an average (though not necessarily an ar-
ithmetic average) of the local properties. However, it may have a pro-
found effect on its strength, because strength depends essentially on
the strength of the weakest link in the chain. This seems to ﬁt well
also to the observation in the present study that the overall modulus
of whole bone is essentially not affected, while the strength is
reduced.It should be kept in mind when considering the results of the pre-
sent study that not all of the expected changes in collagen due to β-
APN administration were monitored. For example, we did not analyze
for pyrroles (important trivalent cross-links), as no microspectro-
scopic parameters have been developed to date describing them,
thus the anatomical spatial distribution could not be established.
In summary, the results of the present study show the good corre-
spondence between biochemically and spectroscopically determined
pyd/divalent collagen cross-link ratio. They suggest that normaliza-
tion for tissue age is critical as it excludes interference in the results
from specimen age induced variability. They also indicate that colla-
gen cross-link alterations, even when limited to certain anatomical
areas (as in the case of the present study where they were conﬁned
to bone forming areas only), coupled with structural properties alter-
ations are capable of affecting the mechanical performance of the
whole bone. Moreover, they are capable of doing so even in the ab-
sence of concomitant alterations in mineral content (as determined
by qBEI) and quality (as determined by FTIR). This may be of particu-
lar importance since previously published analysis of human iliac
crest biopsies from osteoporotic and non-osteoporotic (based on the
classical clinical criteria) patients sustaining atraumatic or low trau-
ma fragility fractures shows similar results as far as collagen cross-
link ratio is concerned [17,18]. Additionally, the results were obtained
in vertebrae, and the incidence of vertebral fractures in osteoporosis
is twice that of hip fractures [70], although caution should be exer-
cised as an animal model was employed in the present study. These
results become even more important in view of the recent clinical re-
ports, which have correlated plasma homocysteine levels and bone
fragility [12–15] when it is noted that the mechanism by which ho-
mocysteine and β-APN block collagen cross-link formation is
analogous.
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